PATENT CLAIM ANALYSIS

Application Number: 16152463
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["514", "183000"]

Abstract:
Concentrated methotrexate solutions are described which are suitable for the use of an active substance in the production of a parenterally administered medicament for the treatment of inflammatory autoimmune diseases. The methotrexate is added to a pharmaceutically acceptable solvent at a concentration of more than 25 mg/ml.

Claim (Index 19):
The method according to  claim 1 , wherein the pharmaceutical solution is contained in a storage container.

Metadata:
- Claim Count in Document: 83.0
- Percentile: 97.0
- Lexical Diversity: 1.28947
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12374528', '14158289', '13257555', '13607659', '15193815']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7598413884120834
- 35 USC 102 Novelty (BERT): 0.5394967075782061
- Combined Prediction Score: 0.7378069203286957
- Mean Citation Score: 209.392768
- Max Citation Score: 362.4949
- Similarity Product: 296.7419546315253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test